CVS Health Corporation $CVS Holdings Raised by Equitable Holdings Inc.

Equitable Holdings Inc. lifted its holdings in CVS Health Corporation (NYSE:CVS) by 21.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 50,408 shares of the pharmacy operator’s stock after purchasing an additional 8,926 shares during the period. Equitable Holdings Inc.’s holdings in CVS Health were worth $5,215,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd grew its position in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares during the last quarter. Swiss RE Ltd. bought a new position in CVS Health during the 4th quarter valued at $26,000. Kilter Group LLC acquired a new position in CVS Health during the second quarter worth about $27,000. Sankala Group LLC bought a new position in shares of CVS Health in the fourth quarter valued at $28,000. Finally, Global Trust Asset Management LLC lifted its stake in CVS Health by 344.8% during the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 300 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Down 1.5%

NYSE CVS opened at $92.88 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The stock’s 50-day moving average is $101.52 and its 200-day moving average is $89.43. The firm has a market cap of $118.79 billion, a P/E ratio of 24.57, a P/E/G ratio of 0.86 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is currently 70.37%.

Analyst Ratings Changes

CVS has been the subject of several recent research reports. DA Davidson boosted their target price on shares of CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Argus increased their price target on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research report on Wednesday, August 19th. Morgan Stanley boosted their target price on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research note on Thursday, June 4th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Finally, UBS Group upped their target price on shares of CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Twenty-two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.